comparemela.com

Advanced Endometrial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study: Chemotherapy, Pembrolizumab Adjuvant Therapy Did Not Improve Disease-Free Survival for Endometrial Cancer

Study: Chemotherapy, Pembrolizumab Adjuvant Therapy Did Not Improve Disease-Free Survival for Endometrial Cancer
pharmacytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmacytimes.com Daily Mail and Mail on Sunday newspapers.

United statesGursel aktanMerck research laboratoriesAmerican cancer societyProvides updateEvaluating keytrudaPatients with newly diagnosedKey statisticsUpdated januaryLenvatinib combination therapyAdvanced endometrial

Exploring Unmet Needs for the LEAP-001 Trial in Advanced Endometrial Cancer

Christian Marth, MD, PhD, discusses the unmet needs that led to the phase 3 LEAP-001 trial in advanced/recurrent endometrial cancer and other research efforts of interest.

Endometrial cancerUnmet needsAdvanced endometrial

Data From the AtTEnd: Study: Atezolizumab Plus Carboplatin and Paclitaxel for Treatment of Advanced Endometrial Cancer

Drs Powell and Backes discuss additional immunotherapy trial results from ESMO 2023 including AtTEnd and DUO-E, noting differences across trials likely due to patient population composition rather than drug differences, and need for caution with PARP inhibitor maintenance.

Post conference perspectives yearRecurrent endometrial cancerAtezolizumab plus carboplatinAdvanced endometrialPost conference perspectivesEndometrial cancerGynecologic cancersEndometrial cancer treatmentsEndometrial cancer treatment updates

Current Data on Single-Agent Immunotherapy in Advanced Endometrial Cancer

Current Data on Single-Agent Immunotherapy in Advanced Endometrial Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Post conference perspectives yearRecurrent endometrial cancerAdvanced endometrial

Optimal Workup Strategies in Advanced Endometrial Cancer

Explore the case of a 67-year-old patient with recurrent endometrial cancer, highlighting the importance of MMR testing, NGS, and emerging treatment options in today's landscape.

Optimizing therapyEndometrial cancerRecent data highlightsWorkup strategiesAdvanced endometrialTreatment approachRecurrent cancerCheckpoint inhibitorMmr testingLynch syndromePole testingHer2 statusEr pr statusEmerging therapiesGynecologic cancerGenetic referrals

vimarsana © 2020. All Rights Reserved.